CA1011748A - Benzylamines - Google Patents

Benzylamines

Info

Publication number
CA1011748A
CA1011748A CA197,507A CA197507A CA1011748A CA 1011748 A CA1011748 A CA 1011748A CA 197507 A CA197507 A CA 197507A CA 1011748 A CA1011748 A CA 1011748A
Authority
CA
Canada
Prior art keywords
benzylamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA197,507A
Other languages
English (en)
Other versions
CA197507S (en
Inventor
Klaus-Reinhold Noll
Helmut Pieper
Gerd Kruger
Johannes Keck
Sigfrid Puschmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19732318636 external-priority patent/DE2318636B2/de
Priority claimed from DE19742402989 external-priority patent/DE2402989C3/de
Priority claimed from DE19742405322 external-priority patent/DE2405322A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of CA1011748A publication Critical patent/CA1011748A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/24Camphidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA197,507A 1973-04-13 1974-04-11 Benzylamines Expired CA1011748A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19732318636 DE2318636B2 (de) 1973-04-13 1973-04-13 Neue benzylamine, sie enthaltende arzneimittel und verfahren zu ihrer herstellung
DE19742402989 DE2402989C3 (de) 1974-01-23 1974-01-23 Neue Benzylamine, sie enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19742405322 DE2405322A1 (de) 1974-02-05 1974-02-05 Neue verfahren zur herstellung von benzylaminen

Publications (1)

Publication Number Publication Date
CA1011748A true CA1011748A (en) 1977-06-07

Family

ID=27185183

Family Applications (1)

Application Number Title Priority Date Filing Date
CA197,507A Expired CA1011748A (en) 1973-04-13 1974-04-11 Benzylamines

Country Status (19)

Country Link
JP (1) JPS5634582B2 (fr)
AT (1) AT332375B (fr)
BG (1) BG25787A3 (fr)
CA (1) CA1011748A (fr)
CH (2) CH609041A5 (fr)
CS (1) CS188920B2 (fr)
DD (1) DD113748A5 (fr)
ES (1) ES424432A1 (fr)
FR (1) FR2225165B1 (fr)
GB (1) GB1469187A (fr)
HU (1) HU167971B (fr)
IE (1) IE40146B1 (fr)
IL (1) IL44623A (fr)
NL (1) NL7404965A (fr)
NO (1) NO138250C (fr)
PL (2) PL89811B1 (fr)
RO (3) RO69152A (fr)
SE (1) SE411749B (fr)
SU (2) SU517250A3 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT327876B (de) * 1974-01-19 1976-02-25 Thomae Gmbh Dr K Verfahren zur herstellung von halogenierten 2-amino-benzylaminen sowie deren saureadditionssalzen
DE2926472A1 (de) * 1979-06-30 1981-01-15 Thomae Gmbh Dr K Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel
DE3100575A1 (de) * 1981-01-10 1982-09-02 Dr. Karl Thomae Gmbh, 7950 Biberach "neue benzoesaeuren, ihre herstellung und ihre verwendung als arzneimittel"
US4735959A (en) * 1981-01-10 1988-04-05 Dr. Karl Thomae Gmbh Carboxylic acid amides and pharmaceutical compositions containing them
JPS60146849A (ja) * 1984-01-09 1985-08-02 Mitsui Toatsu Chem Inc アミノベンジルアミンの製造方法
JPH0365264A (ja) * 1989-08-03 1991-03-20 Sanko Denki Seisakusho:Kk 霧化装置
DE19529431C1 (de) * 1995-08-10 1996-12-12 Boehringer Ingelheim Kg Verfahren zur Herstellung von Benzylaminderivaten
CN112279774B (zh) * 2019-07-24 2023-05-30 成都施贝康生物医药科技有限公司 二溴苄基衍生物、其立体异构体或其盐及制法和应用

Also Published As

Publication number Publication date
CH609327A5 (en) 1979-02-28
JPS5012030A (fr) 1975-02-07
FR2225165A1 (fr) 1974-11-08
PL89811B1 (fr) 1976-12-31
GB1469187A (en) 1977-03-30
DD113748A5 (fr) 1975-06-20
FR2225165B1 (fr) 1977-09-09
IL44623A (en) 1978-01-31
IL44623A0 (en) 1974-06-30
JPS5634582B2 (fr) 1981-08-11
RO70260A (fr) 1980-03-15
NL7404965A (fr) 1974-10-15
NO138250B (no) 1978-04-24
IE40146B1 (en) 1979-03-28
HU167971B (en) 1976-01-28
IE40146L (en) 1974-10-13
CS188920B2 (en) 1979-03-30
ATA202374A (de) 1976-01-15
SE411749B (sv) 1980-02-04
NO138250C (no) 1978-08-02
RO69152A (fr) 1981-01-30
AT332375B (de) 1976-09-27
PL102867B1 (pl) 1979-04-30
NO741350L (no) 1974-10-15
BG25787A3 (en) 1978-12-12
RO69291B (ro) 1983-04-30
RO69291A (fr) 1983-04-29
CH609041A5 (en) 1979-02-15
SU521836A3 (ru) 1976-07-15
SU517250A3 (ru) 1976-06-05
ES424432A1 (es) 1976-06-01

Similar Documents

Publication Publication Date Title
AU474137B2 (en) Auto-refractometer
AU468964B2 (en) Melik
AU475303B2 (en) Novel cyclopropanecaboxlates
CA1010130A (en) Terminating ribbon-conductors
AU498889B2 (en) Piperidylene benzocycloheptathiophenes
AU476397B2 (en) A-cycloalkylbenzyl lactamimides
AU476505B2 (en) Alkylbenxyl lactamimides
CA1011748A (en) Benzylamines
AU472907B2 (en) Firecheck
AU476386B2 (en) Dibenzocycloheptenyl lactamimides
AU489908B2 (en) Benzylamines
AU471241B2 (en) Benzothiazolylureas
AU6778374A (en) Benzylamines
AU486365B2 (en) Novel pseudotrisaccharides
AU484442B2 (en) Novel benzylpyrimidines
AU486644B2 (en) Fusebox
AU479426B2 (en) Carbothiolates
AU478880B2 (en) 3-isoxazolidinones
AU481998B2 (en) Benzenedisulfonamides
AU466103B2 (en) Cis-chrysanthemate
AU482276B2 (en) Spiro-cyclopropanes
AU492247B2 (en) Ethenoanthracenes
AU492165B2 (en) 2-hydroxyphenyl-1-oxa-4 azaspiro-alkan-derivatives
AU492033B2 (en) D-homo-20-keto-pregnanes
AU491458B2 (en) 7-halomethyl-17-hydroxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones